sibutramine Meridia withdrawn
Selected indexed studies
- Sibutramine (Meridia) withdrawn. (Med Lett Drugs Ther, 2010) [PMID:21045763]
- Emerging pharmacotherapies for obesity: A systematic review. (Pharmacol Rev, 2025) [PMID:39952695]
- Sibutramine. (, 2012) [PMID:31643572]
_Worker-drafted node — pending editorial review._
Connections
sibutramine Meridia withdrawn is a side effect of
Sources
- Emerging pharmacotherapies for obesity: A systematic review. (2025) pubmed
- Weight Loss Agents. (2012) pubmed
- Obesity drug therapy. (2013) pubmed
- Safety of obesity drugs. (2005) pubmed
- Sibutramine (Meridia) withdrawn. (2010) pubmed
- Sibutramine. (2012) pubmed
- Pharmacotherapy of obesity. (2004) pubmed
- Pharmacological therapies for obesity. (2005) pubmed
- The effect of sibutramine prescribing in routine clinical practice on cardiovascular outcomes: a cohort study in the United Kingdom. (2015) pubmed
- Sibutramine lost and found. (2002) pubmed